HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manjusha Gaglani Selected Research

Ambulatory Care (Outpatient Care)

4/2022Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
3/2022Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.
2/2022Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
10/2021Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.
12/2020Reducing Antibiotic Use in Ambulatory Care Through Influenza Vaccination.
1/2020Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19.
1/2020Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness.
1/2016Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States.
9/2014Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manjusha Gaglani Research Topics

Disease

59Human Influenza (Influenza)
10/2022 - 02/2014
35COVID-19
11/2022 - 01/2021
24Infections
10/2022 - 02/2014
3Breakthrough Infections
01/2022 - 01/2021
2Disease Progression
10/2022 - 11/2021
2Pneumonia (Pneumonitis)
01/2022 - 01/2018
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2020 - 01/2018
2Cough
01/2020 - 05/2016
1Coinfection
10/2022
1Thrombosis (Thrombus)
04/2022
1Thrombocytopenia (Thrombopenia)
04/2022
1Respiratory Insufficiency (Respiratory Failure)
03/2022
1Asymptomatic Infections
08/2021
1Drug-Related Side Effects and Adverse Reactions
12/2020
1Frailty
01/2019
1Fever (Fevers)
01/2018
1Sinusitis
01/2018
1Pharyngitis (Sore Throat)
01/2018
1Bronchitis
01/2018
1Herpesviridae Infections (Herpesvirus Infection)
02/2014
1Mumps
10/2011
1Rubella (German Measles)
10/2011
1Measles
10/2011
1Chickenpox
10/2011

Drug/Important Bio-Agent (IBA)

74VaccinesIBA
11/2022 - 10/2011
38Influenza Vaccines (Influenza Vaccine)FDA Link
03/2022 - 02/2014
23mRNA VaccinesIBA
10/2022 - 01/2021
18COVID-19 VaccinesIBA
10/2022 - 04/2021
16Messenger RNA (mRNA)IBA
11/2022 - 01/2021
10BNT162 VaccineIBA
08/2022 - 01/2021
7RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2022 - 02/2014
6Antiviral Agents (Antivirals)IBA
03/2022 - 02/2014
52019-nCoV Vaccine mRNA-1273IBA
08/2022 - 01/2021
5Hemagglutinins (Hemagglutinin)IBA
01/2021 - 01/2015
3AntibodiesIBA
10/2022 - 01/2015
3Neutralizing AntibodiesIBA
08/2022 - 01/2022
3Anti-Bacterial Agents (Antibiotics)IBA
12/2020 - 09/2014
2Ad26COVS1IBA
10/2022 - 10/2021
2Inactivated VaccinesIBA
01/2021 - 12/2018
2Attenuated VaccinesIBA
01/2021 - 10/2017
2Neuraminidase (Sialidase)IBA
09/2016 - 01/2015
1Proteins (Proteins, Gene)FDA Link
10/2022
1NucleoproteinsIBA
10/2022
1COVID-19 vaccine booster shotIBA
04/2022
1Dihydrotachysterol (AT 10)IBA
12/2021
1Nucleic AcidsIBA
11/2021
1Immunoglobulin G (IgG)IBA
09/2021
1Combined VaccinesIBA
01/2021
1Viral RNAIBA
01/2021
1CI 22IBA
01/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019
1Hepatitis A Vaccines (Hepatitis A Vaccine)IBA
10/2011

Therapy/Procedure

9Ambulatory Care (Outpatient Care)
04/2022 - 09/2014
2Artificial Respiration (Mechanical Ventilation)
10/2022 - 11/2021
1Critical Care (Surgical Intensive Care)
01/2022
1Mechanical Ventilators (Ventilator)
12/2021
1Length of Stay
12/2021
1Therapeutics
09/2014